Showing results (341-350 of 485) with videos related to
Sort By:
Pageof 49
International Journal of Urology : Official Journal of the Japanese Urological Association|July 26, 2019
C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinomaSakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, et al.Oncotarget|April 19, 2017
GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosisRyuta Inoue, Yoshihiko Hirohashi, Hiroshi Kitamura, et al.Cancer Medicine|July 22, 2022
Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort studyKatsuhiro Ito, Yuki Kita, Akira Yokomizo, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 11, 2025
Impact of lymph node dissection during surgery on the efficacy of pembrolizumab in patients with metastatic urothelial carcinomaToru Kanno, Katsuhiro Ito, Yuki Kita, et al.Journal of Clinical Medicine|November 9, 2024
Impact of Mannitol Administration on Postoperative Renal Function After Robot-Assisted Partial NephrectomyKazuki Taniguchi, Tomoki Taniguchi, Kentaro Muraoka, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 1, 2026
Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter StudyShunya Matsumoto, Hajime Tanaka, Yuto Matsushita, et al.Proceedings of the National Academy of Sciences of the United States of America|August 14, 2014
KLRG+ invariant natural killer T cells are long-lived effectorsKanako Shimizu, Yusuke Sato, Jun Shinga, et al.Experimental Neurology|September 13, 2011
Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical studyKazumoto Shibuya, Sonoko Misawa, Kimihito Arai, et al.Clinical Genitourinary Cancer|January 10, 2017
Second-line Chemotherapy in Older Patients With Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-line StudiesSamer Salah, Jae-Lyun Lee, Antonio Rozzi, et al.Current Oncology (Toronto, Ont.)|June 25, 2026
Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group)Risa Tomioka-Inagawa, Masayuki Tomioka, Tomoyuki Tatenuma, et al.Pageof 49